Published in Am J Physiol Endocrinol Metab on December 29, 2004
The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol (2014) 1.42
High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep (2008) 0.95
Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics. Biol Psychiatry (2016) 0.80
Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits (2016) 0.78
miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias. Sleep (2014) 0.78
Growing Up With Type 1 Narcolepsy: Its Anthropometric and Endocrine Features. J Clin Sleep Med (2016) 0.75
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Thyroid status, disability and cognitive function, and survival in old age. JAMA (2004) 5.39
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol (2002) 4.03
Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol (2008) 3.32
Vitamin B12 and folate and the risk of anemia in old age: the Leiden 85-Plus Study. Arch Intern Med (2008) 2.90
Hypophosphatemia: an update on its etiology and treatment. Am J Med (2005) 2.85
No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med (2002) 2.79
Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology (2005) 2.30
Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc (2009) 2.30
Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol (2005) 2.16
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial. Lancet Neurol (2009) 2.01
Hypocretin (orexin) loss in Parkinson's disease. Brain (2007) 1.98
Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke (2006) 1.93
Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc (2007) 1.91
Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain (2010) 1.76
Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. Diabetes (2002) 1.75
A 5-day high-fat, high-calorie diet impairs insulin sensitivity in healthy, young South Asian men but not in Caucasian men. Diabetes (2014) 1.74
Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol (2004) 1.72
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol (2013) 1.71
Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J Gerontol A Biol Sci Med Sci (2009) 1.70
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet (2010) 1.67
Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease. Clin Endocrinol (Oxf) (2004) 1.62
Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol (2007) 1.62
Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT). Lancet Neurol (2013) 1.60
Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial. BMJ (2013) 1.57
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial. Mov Disord (2012) 1.54
Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.52
Cataplexy: 'tonic immobility' rather than 'REM-sleep atonia'? Sleep Med (2002) 1.51
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care (2004) 1.46
Physiological control of pituitary hormone secretory-burst mass, frequency, and waveform: a statistical formulation and analysis. Am J Physiol Regul Integr Comp Physiol (2003) 1.45
Hypocretin/orexin disturbances in neurological disorders. Sleep Med Rev (2008) 1.45
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care (2007) 1.36
Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study. J Am Geriatr Soc (2010) 1.33
Familial longevity is marked by enhanced insulin sensitivity. Aging Cell (2010) 1.32
Narcolepsy: immunological aspects. Sleep Med Rev (2008) 1.28
Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease. Arch Gen Psychiatry (2009) 1.27
Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab (2005) 1.25
Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve (2010) 1.24
Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab (2010) 1.23
Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes (2004) 1.20
Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr (2005) 1.20
Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res (2003) 1.19
Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation. Diabetes (2008) 1.19
Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes (2003) 1.19
Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol (2004) 1.18
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord (2010) 1.18
Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab (2006) 1.17
Expectancy induces dynamic modulation of corticospinal excitability. J Cogn Neurosci (2007) 1.17
Corticospinal beta-band synchronization entails rhythmic gain modulation. J Neurosci (2010) 1.17
Human insulin/IGF-1 and familial longevity at middle age. Aging (Albany NY) (2009) 1.16
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry (2002) 1.16
Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in The Netherlands. Pediatrics (2005) 1.14
Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol (2005) 1.12
Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab (2004) 1.11
Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes (2007) 1.09
The ParkinsonNet concept: development, implementation and initial experience. Mov Disord (2010) 1.08
Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism (2005) 1.08
Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord (2011) 1.07
Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats. Diabetes (2006) 1.07
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res (2013) 1.07
Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion. Am J Physiol Endocrinol Metab (2007) 1.07
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics. Curr Control Trials Cardiovasc Med (2002) 1.07
Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes. Diabetes (2007) 1.07
Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index. J Clin Endocrinol Metab (2009) 1.06
Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry (2009) 1.06
Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging (2011) 1.05
Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab (2006) 1.05
Altered skin-temperature regulation in narcolepsy relates to sleep propensity. Sleep (2006) 1.05
Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep (2006) 1.04
The inferior frontal cortex in artificial syntax processing: an rTMS study. Brain Res (2008) 1.04
Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) (2008) 1.04
Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2. J Neurol Neurosurg Psychiatry (2010) 1.03
Effects of olanzapine and haloperidol on the metabolic status of healthy men. J Clin Endocrinol Metab (2009) 1.03
Is motor inhibition during laughter due to emotional or respiratory influences? Psychophysiology (2004) 1.02
Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab (2009) 1.02
Dose-response downregulation within the span of single interpulse intervals. Am J Physiol Regul Integr Comp Physiol (2010) 1.02